Last reviewed · How we verify
NCT07443618
Measuring Fluid Buildup in Cancer Patients
trial in Cancer in 46 participants. Not yet recruiting.
31 July 2026
Quick facts
| Lead sponsor | Jens Rikardt Andersen |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 46 |
| Start date | 1 February 2026 |
| Primary completion | 31 July 2026 |
| Estimated completion | 31 July 2026 |
| Sites | 1 location across Denmark |
Conditions studied
- Cancer — all drugs for Cancer →
- Oedema — all drugs for Oedema →
- Bioelectrical Impedance — all drugs for Bioelectrical Impedance →
- Lymphoedema — all drugs for Lymphoedema →
Sponsor
Jens Rikardt Andersen — full company profile →
Who can join
18 and older, any sex, with Cancer or Oedema. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to improve the monitoring of fluid retention in cancer patients. The main question it aims to answer is: Can segmental bioelectrical impedance analysis be used to monitor local fluid retention (edema) in cancer patients? We will include: * Breast cancer patients with fluid and or lymph retention in one or both arms after radiotherapy (outpatients) * Cancer patients with fluid retention in one or both legs after chemotherapy (hospitalized) Participants will: * Have measurements taken using bioelectrical impedance * Provide blood samples and 24-hour urine collection * Weight monitorering * Complete diet and fluid registration (inclusive enteral and parenteral) * Have clinical palpatory and measurement assessment of oedema.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07443618
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other Jens Rikardt Andersen trials
Trials by the same sponsor.
- NCT05415982 — Diet Induced Ketosis for Patients With Posttraumatic Stress Disorder (PTSD), a Feasibility Study · NA · completed
- NCT04846985 — Nutritional Problems in Pallative Cancer · completed
- NCT05209321 — Predictors of Malnutrition in Patients With Haematological Cancer · completed
- NCT04754256 — Causes of Appetite Loss in Patients With Chronic Obstructive Pulmonary Disease (COPD) · completed
- NCT04308577 — Diet Induced Ketosis for Brain Injury - A Feasibility Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07443618 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jens Rikardt Andersen
- Last refreshed: 2 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07443618.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing